αB-crystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts

Free Radical Biology and Medicine

Volumn 49, Issue 3, 2010, Pages 374-382

  Mercatelli, Neri ^a   Dimauro, Ivan ^b   Ciafré, Silvia Anna ^a   Farace, Maria Giulia ^a   Caporossi, Daniela ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

B crystallin; Apoptosis; Free radicals; Oxidative stress; Skeletal myoblasts; VEGF

Indexed keywords

ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMID VECTOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; BCL2L1 PROTEIN, MOUSE; HYDROGEN PEROXIDE; PROTEIN BCL 2; PROTEIN BCL X;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL HYPOXIA; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REGENERATION; RNA INTERFERENCE;

ALPHA-CRYSTALLIN B CHAIN; ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL LINE; HYDROGEN PEROXIDE; MICE; MYOBLASTS, SKELETAL; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REGENERATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77954142571     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.04.027     Document Type: Article

References (41)

1. Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 2006, 312:549-560.
2. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
3. Breen E.C. VEGF in biological control. J. Cell. Biochem. 2007, 102:1358-1367.
4. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005, 14:207-221.
5. Sun F.Y., Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J. Neurosci. Res. 2005, 79:180-184.
6. Germani A., Di Carlo A., Mangoni A., Straino S., Giacinti C., Turrini P., Biglioli P., Capogrossi M.C. Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol. 2003, 163:1417-1428.
7. Deasy B.M., Feduska J.M., Payne T.R., Li Y., Ambrosio F., Huard J. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol. Ther. 2009, 17:1788-1798.
8. Rissanen T.T., Vajanto I., Hiltunen M.O., Rutanen J., Kettunen M.I., Niemi M., Leppanen P., Turunen M.P., Markkanen J.E., Arve K., Alhava E., Kauppinen R.A., Yla-Herttuala S. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002, 160:1393-1403.
9. Arsic N., Zacchigna S., Zentilin L., Ramirez-Correa G., Pattarini L., Salvi A., Sinagra G., Giacca M. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol. Ther. 2004, 10:844-854.
10. Jackson M.J. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function?. Free Radic. Biol. Med. 2008, 44:132-141.
11. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
12. Catani M.V., Savini I., Duranti G., Caporossi D., Ceci R., Sabatini S., Avigliano L. Nuclear factor kappaB and activating protein 1 are involved in differentiation-related resistance to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 2004, 37:1024-1036.
13. 2-simulated hypoxia in skeletal muscle cell lines: role of free radicals in gene up-regulation and induction of apoptosis. Free Radic. Res. 2007, 4:391-401.
14. Perry R.L., Rudnick M.A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 2000, 5:D750-D767.
15. Kaminski K.A., Bonda T.A., Korecki J., Musial W.J. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. Int. J. Cardiol. 2002, 86:41-59.
16. Chanock S.J. el Benna, J., Smith, R. M., Babior, B. M. The respiratory burst oxidase. J. Biol. Chem. 1994, 269:24519-24522.
17. Gute D.C., Ishida T., Yarimizu K., Korthuis R.J. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol. Cell. Biochem. 1998, 179:169-187.
18. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 1997, 3:970-977.
19. 165 and angiopoietin-1. J. Heart Lung Transplant. 2005, 24:1393-1402.
20. Ye L., Haider H.K., Tan R.S., Toh W.C., Law P.K., Tan W.B., Su L.P., Zhang W., Ge R.W., Zhang Y., Lim Y.T., Sim E.K.W. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation 2007, 116(Suppl. 1):I-113-I-120.
21. + cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 2004, 18:1737-1739.
22. Iwaki T., Iwaki A., Goldman J.E. Alpha B-crystallin in oxidative muscle fibers and its accumulation in ragged-red fibers: a comparative immunohistochemical and histochemical study in human skeletal muscle. Acta Neuropathol. 1993, 85:475-480.
23. Ferrer I., Olivé M. Molecular pathology of myofibrillar myopathies. Expert Rev. Mol. Med. 2008, 3:10-25.
24. Boonstra J., Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004, 337:1-13.
25. 2 and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic. Biol. Med. 2003, 35:1355-1364.
26. Shiote M., Nagano I., Ilieva H., Murakami T., Narai H., Ohta Y., Nagata T., Shoji M., Abe K. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia. Neuroscience 2005, 132:175-182.
27. Dai Y., Xu M., Wang Y., Pasha Z., Li T., Ashraf M. HIF-1 alpha-induced VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J. Mol. Cell. Cardiol. 2007, 42:1036-1044.
28. Ferrari G., Pintucci G., Seghezzi G., Hyman K., Galloway A.C., Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl Acad. Sci. USA 2006, 103:17260-17265.
29. Papa S., Bubici C., Zazzeroni F., Pham C.G., Kuntzen C., Knabb J.R., Dean K., Franzoso G. The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 2006, 13:712-729.
30. Franke T.F., Hornik C.P., Segev L., Shostak G.A., Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003, 22:8983-8998.
31. Dominov J.A., Dunn J.J., Miller J.B. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J. Cell Biol. 1998, 142:537-544.
32. Kamradt M.C., Chen F., Sam S., Cryns V.L. The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J. Biol. Chem. 2002, 277:38731-38736.
33. Murray T.V., McMahon J.M., Howley B.A., Stanley A., Ritter T., Mohr A., Zwacka R., Fearnhead H.O. A non-apoptotic role for caspase-9 in muscle differentiation. J. Cell Sci. 2008, 121:3786-3793.
34. Yaung J., Jin M., Barron E., Spee C., Wawrousek E.F., Kannan R., Hinton D.R. alpha-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress. Mol. Vis. 2007, 13:566-577.
35. Liu B.F., Bhat M., Nagaraj R.H. αB-crystallin inhibits glucose-induced apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2004, 321:254-258.
36. Nagaraj R.H., Oya-Ito T., Bhat M., Liu B.F. Dicarbonyl stress and apoptosis of vascular cells: prevention by αB-crystallin. Ann. NY Acad. Sci. 2005, 1043:158-165.
37. Arrigo A.P., Simon S., Gibert B., Kretz-Remy C., Nivon M., Czekalla A., Guillet D., Moulin M., Diaz-Latoud C., Vicart P. Hsp27 (HspB1) and aB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 2007, 581:3665-3674.
38. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 2002, 277:3101-3108.
39. Evans I.M., Britton G., Zachary I.C. Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. Cell. Signal. 2008, 20:1375-1384.
40. Pawlowska Z., Baranska P., Jerczynska H., Koziolkiewicz W., Cierniewski C.S. Heat shock proteins and other components of cellular machinery for protein synthesis are up-regulated in vascular endothelial cell growth factor-activated human endothelial cells. Proteomics 2005, 5:1217-1227.
41. Parcellier A., Schmitt E., Gurbuxani S., Seigneurin-Berny D., Pance A., Chantôme A., Plenchette S., Khochbin S., Solary E., Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol. Cell. Biol. 2003, 23:5790-5802.